Nanoparticle flu vaccine protects against three influenza strains in mice

A new nanoparticle vaccine could one day give patients immunity to the flu with fewer trips to the doctor and without requiring health officials to correctly guess which flu strains will become dominant each year.

The top 3

  1. mRNA Vaccines: Rapid Design & Adaptability: mRNA vaccines, notably accelerated by the COVID-19 pandemic, offer unprecedented speed in design and production, high immunogenicity, and adaptability to new pathogens due to their cell-independent manufacturing process and non-infectious nature.
  2. Nanoparticle Vaccines: Broad & Durable Protection: Nanoparticle vaccines, like the I53cs platform designed with AI, are emerging as a versatile platform for next-generation vaccines, displaying antigens in a highly ordered manner to enhance immunogenicity and offer broader, longer-term protection against various flu subtypes.
  3. Viral Vector Vaccines: Targeted Antigen Delivery: Viral vector vaccines utilize a harmless carrier virus to deliver genetic instructions to human cells, prompting them to produce specific antigens and trigger a strong immune response against the targeted disease.

Sources

Open the full topic